Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A vaccine for malaria.

Authors: K Sony Reddy; Alok K Pandey; Hina Singh; Tajali Sahar; Amlabu Emmanuel; Chetan E Chitnis; Virander S Chauhan; Deepak Gaur
Journal: Infect Immun Date: 2013-10-14 Impact factor: 3.441

5. A Prime/Boost PfCS14K^M/MVA-sPfCS^M Vaccination Protocol Generates Robust CD8⁺ T Cell and Antibody Responses to Plasmodium falciparum Circumsporozoite Protein and Protects Mice against Malaria.

Authors: Aneesh Vijayan; Ernesto Mejías-Pérez; Diego A Espinosa; Suresh C Raman; Carlos Oscar S Sorzano; Fidel Zavala; Mariano Esteban
Journal: Clin Vaccine Immunol Date: 2017-05-05

6. Inhibitory humoral responses to the Plasmodium falciparum vaccine candidate EBA-175 are independent of the erythrocyte invasion pathway.

Authors: Aida S Badiane; Amy K Bei; Ambroise D Ahouidi; Saurabh D Patel; Nichole Salinas; Daouda Ndiaye; Ousmane Sarr; Omar Ndir; Niraj H Tolia; Souleymane Mboup; Manoj T Duraisingh
Journal: Clin Vaccine Immunol Date: 2013-06-12

Review 7. Correlates of protective immunity following whole sporozoite vaccination against malaria.

Authors: Katherine L Doll; John T Harty
Journal: Immunol Res Date: 2014-08 Impact factor: 2.829

Review 8. Pathogenesis of malaria revisited.

Authors: Prasad Dasari; Sucharit Bhakdi
Journal: Med Microbiol Immunol Date: 2012-09-07 Impact factor: 3.402

Review 9. A review of malaria vaccine clinical projects based on the WHO rainbow table.

Authors: Lauren Schwartz; Graham V Brown; Blaise Genton; Vasee S Moorthy
Journal: Malar J Date: 2012-01-09 Impact factor: 2.979

Review 10. Experience and challenges from clinical trials with malaria vaccines in Africa.

Authors: Grace Mwangoka; Bernhards Ogutu; Beverly Msambichaka; Tutu Mzee; Nahya Salim; Shubis Kafuruki; Maxmillian Mpina; Seif Shekalaghe; Marcel Tanner; Salim Abdulla
Journal: Malar J Date: 2013-03-04 Impact factor: 2.979

A vaccine for malaria.

1. What is the efficacy of the RTS,S malaria vaccine?

2. Malaria vaccine results face scrutiny.

Review 3. Adjuvants for human vaccines.

4. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.